Debt-to-equity in % of Greenwich LifeSciences, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Greenwich LifeSciences, Inc. quarterly Debt-to-equity history and change rate from Q2 2021 to Q3 2025.
  • Greenwich LifeSciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 84.4 %, a 565% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Greenwich LifeSciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 84.4 +71.7 +565% 30 Sep 2025
Q2 2025 53.8 +45 +512% 30 Jun 2025
Q1 2025 35.3 +31.2 +762% 31 Mar 2025
Q4 2024 22.4 +19.4 +651% 31 Dec 2024
Q3 2024 12.7 +10.2 +414% 30 Sep 2024
Q2 2024 8.79 +6.76 +332% 30 Jun 2024
Q1 2024 4.1 +2.41 +143% 31 Mar 2024
Q4 2023 2.98 +1.49 +99.9% 31 Dec 2023
Q3 2023 2.47 +1.08 +77.8% 30 Sep 2023
Q2 2023 2.04 +0.61 +42.7% 30 Jun 2023
Q1 2023 1.69 +0.02 +1.2% 31 Mar 2023
Q4 2022 1.49 -0.41 -21.6% 31 Dec 2022
Q3 2022 1.39 -1.07 -43.5% 30 Sep 2022
Q2 2022 1.43 -2.94 -67.2% 30 Jun 2022
Q1 2022 1.67 31 Mar 2022
Q4 2021 1.9 31 Dec 2021
Q3 2021 2.46 30 Sep 2021
Q2 2021 4.37 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.